Evolution AB (publ)
STO:EVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evolution AB (publ)
STO:EVO
|
SE |
|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
JP |
|
R
|
Resource Base Ltd
ASX:RBX
|
AU |
|
K
|
Kimberly-Clark Corp
F:KMY
|
US |
|
Toyota Motor Corp
NYSE:TM
|
JP |
|
Sibanye Stillwater Ltd
F:47VS
|
ZA |
Wall St Price Targets
EVO Price Targets Summary
Evolution AB (publ)
According to Wall Street analysts, the average 1-year price target for EVO is 717.57 SEK with a low forecast of 510.05 SEK and a high forecast of 1 155 SEK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVO's stock price target?
Price Target
717.57
SEK
According to Wall Street analysts, the average 1-year price target for EVO is 717.57 SEK with a low forecast of 510.05 SEK and a high forecast of 1 155 SEK.
What is the Revenue forecast for Evolution AB (publ)?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for Evolution AB (publ)?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Operating Income has been 51%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Evolution AB (publ)?
Projected CAGR
4%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 52%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Evolution AB (publ)?
Projected CAGR
3%
Over the last 12 years, the compound annual growth rate for Net Income has been 52%. The projected CAGR for the next 3 years is 3%.